JFRNX | VIGAX | JFRNX / VIGAX | |
Total Expense Ratio | 0.52 | 0.05 | 1,040% |
Annual Report Gross Expense Ratio | 0.52 | 0.05 | 1,040% |
Fund Existence | 13 years | 25 years | - |
Gain YTD | -5.359 | -5.511 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 3000 | 33,333% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 19.8B | 269B | 7% |
Annual Yield % from dividends | 0.20 | 0.50 | 40% |
Returns for 1 year | -0.53 | 12.82 | -4% |
Returns for 3 years | 34.58 | 63.99 | 54% |
Returns for 5 years | 37.03 | 109.54 | 34% |
Returns for 10 years | 63.64 | 259.34 | 25% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
GWX | 34.31 | 0.28 | +0.82% |
SPDR® S&P® International Small Cap ETF | |||
DXJS | 35.39 | 0.27 | +0.77% |
WisdomTree Japan Hedged SmallCap Eq ETF | |||
DSI | 105.01 | -0.09 | -0.09% |
iShares ESG MSCI KLD 400 ETF | |||
JCHI | 47.16 | -0.15 | -0.32% |
JPMorgan Active China ETF | |||
PJP | 78.43 | -0.97 | -1.22% |
Invesco Pharmaceuticals ETF |